MedTrace Logo

Gene Expression in Tissue From Patients With Acute Lymphoblastic Leukemia

NCT00898261 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 137

Last updated 2017-05-19

No results posted yet for this study

Summary

RATIONALE: Studying the genes expressed in samples of tumor tissue from patients with cancer may help doctors identify biomarkers related to cancer.

PURPOSE: This laboratory study is looking at gene expression in tissue from patients with acute lymphoblastic leukemia enrolled in clinical trial ECOG-2993.

Conditions

Interventions

GENETIC

microarray analysis

GENETIC

reverse transcriptase-polymerase chain reaction

OTHER

flow cytometry

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • ECOG-ACRIN Cancer Research Group

    lead NETWORK

Principal Investigators

  • Elisabeth Paietta, PhD · Our Lady of Mercy Medical Center

Eligibility

Min Age
15 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-26
Primary Completion
2012-07-19
Completion
2012-07-19

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00898261 on ClinicalTrials.gov